(Q34546913)

2 August 2017

1 reference

title

Blood transfusion for preventing stroke in people with sickle cell disease (English)

1 reference

2 August 2017

0 references

C Riddington

1

1 reference

2 August 2017

W Wang

series ordinal

2

1 reference

2 August 2017

language of work or name

1 reference

1 January 2002

1 reference

Cochrane Database of Systematic Reviews

2 August 2017

published in

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

CD003146

1 reference

Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Lessons from the Stroke Prevention Trial in Sickle Cell Anemia (STOP) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Alpha Thalassemia is associated with decreased risk of abnormal transcranial Doppler ultrasonography in children with sickle cell anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Elevated blood flow velocity in the anterior cerebral artery and stroke risk in sickle cell disease: extended analysis from the STOP trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Regular transfusion lowers plasma free hemoglobin in children with sickle-cell disease at risk for stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Stroke prevention in sickle cell disease (STOP) study guidelines for transcranial Doppler testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Erythrocytapheresis can reduce iron overload and prevent the need for chelation therapy in chronically transfused pediatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Stroke prevention trial in sickle cell anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Blood transfusion in sickle cell disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Mapping the prevalence of sickle cell and beta thalassaemia in England: estimating and validating ethnic-specific rates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Hydroxyurea for sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Mortality in sickle cell disease. Life expectancy and risk factors for early death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Management of cerebral vasculopathy in children with sickle cell anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Management of sickle cell disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Effects of a long-term transfusion regimen on sickle cell-related illnesses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Effect of long-term transfusion on growth in children with sickle cell anemia: results of the STOP trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Transcranial Doppler (TCD) screening for stroke prevention in sickle cell anemia: pitfalls in technique variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Sickle cell disease--new treatments, new questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Longitudinal changes in ferritin during chronic transfusion: a report from the Stroke Prevention Trial in Sickle Cell Anemia (STOP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Stroke prevention trial in sickle cell anemia: comments on effects of chronic transfusion on pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Transcranial Doppler correlation with cerebral angiography in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Discontinuation of long-term transfusion therapy in patients with sickle cell disease and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003146

10.1002/14651858.CD003146

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference